OR52N1

Across TCGA pan-cancer cohorts, OR52N1 RNA is linked to patient survival in 15 of 34 cancer types, making it the most broadly survival-associated OR52N1 data layer compared with 6 for mutation status.

The strongest signal is observed in lung adenocarcinoma (LUAD), where higher OR52N1 RNA is associated with better disease-free survival. In most high-consensus cancer types, elevated OR52N1 expression acts as an unfavorable survival marker, although some lineages such as LUAD and OV show a favorable association.

LUAD, READ, and OV are the cancer types where OR52N1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUAD	DFS	Tertile	All	0.693	0.304	.001	72	view →
READ	DFS	Tertile	All	0.150	0.566	.009	45	view →
OV	OS	Tertile	IV	0.954	0.562	.021	42	view →
KIRP	DFS	Tertile	All	0.281	0.641	.003	33	view →
HNSC	DFS	Tertile	All	0.137	0.333	.016	30	view →
PCPG	DFS	Tertile	All	0.367	0.856	.002	27	view →
ACC	DFS	Tertile	IV	0.039	0.407	.004	18	view →
UCEC	OS	Tertile	All	0.839	0.930	.018	18	view →
THYM	OS	Tertile	All	0.700	0.974	.003	15	view →
ESCA	DFS	Quartile	IV	0.826	0.306	.040	12	view →
LAML	DFS	Quartile	All	0.365	0.675	.015	12	view →
LIHC	DFS	Tertile	All	0.407	0.564	.007	12	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 15 lineages.

OR52N1–LUAD (DFS)

Open the LUAD breakdown →